Investitionen in Aktie Atrium Therapeutics, Inc. (RNA)

Fonds	2026/Q1
	Investment ($)	QoQ ($)	QoQ (%)
	156.906.721 $
PRICE T ROWE ASSOCIATES INC /MD/	20.767.000 $
BlackRock, Inc.	16.114.735 $
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13.773.012 $
RA CAPITAL MANAGEMENT, L.P.	11.553.044 $
VANGUARD CAPITAL MANAGEMENT LLC	8.381.239 $
TIG Advisors, LLC	8.122.970 $
Pentwater Capital Management LP	8.057.417 $
O'Connor Alternative Investments LLC	7.728.007 $
Sessa Capital IM, L.P.	7.372.098 $
GOLDMAN SACHS GROUP INC	4.678.831 $
FARALLON CAPITAL MANAGEMENT, L.L.C.	4.670.943 $
VANGUARD PORTFOLIO MANAGEMENT LLC	4.604.214 $
GEODE CAPITAL MANAGEMENT, LLC	4.277.244 $
683 Capital Management, LLC	4.011.000 $
Bellevue Group AG	3.517.594 $
STATE STREET CORP	3.437.240 $
Weiss Asset Management LP	3.218.172 $
CANTOR FITZGERALD, L. P.	3.150.467 $
BALYASNY ASSET MANAGEMENT L.P.	3.143.488 $
Squarepoint Ops LLC	3.094.700 $
Arbiter Partners Capital Management LLC	3.075.100 $
Caption Management, LLC	2.732.721 $
MILLENNIUM MANAGEMENT LLC	2.551.785 $
ADAGE CAPITAL PARTNERS GP, L.L.C.	2.454.465 $
Slotnik Capital, LLC	2.419.235 $
	156.906.721 $